PENILE SQUAMOUS CELL CARCINOMA (PSCC)

Clinical trials for PENILE SQUAMOUS CELL CARCINOMA (PSCC) explained in plain language.

Never miss a new study

Get alerted when new PENILE SQUAMOUS CELL CARCINOMA (PSCC) trials appear

Sign up with your email to follow new studies for PENILE SQUAMOUS CELL CARCINOMA (PSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug duo targets Tough-to-Treat penile cancer

Disease control Recruiting now

This study is testing a new combination of two existing drugs, enfortumab vedotin and avelumab, as a first treatment for men with advanced penile cancer that has spread or cannot be removed by surgery. The main goal is to see how well the combination shrinks tumors and controls t…

Matched conditions: PENILE SQUAMOUS CELL CARCINOMA (PSCC)

Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated Mar 09, 2026 14:25 UTC

PENILE SQUAMOUS CELL CARCINOMA (PSCC)

Get alerted when new PENILE SQUAMOUS CELL CARCINOMA (PSCC) trials appear

New drug duo targets Tough-to-Treat penile cancer